Product Information
ERYTHROMYCIN 2% SOLUTION is a generic product labeled by Saptalis Pharmaceuticals LLC, priced at $0.3520 per ML under NDC 71656003060. Its NADAC has been published 97 times since Nov 27, 2024.
FDA first approved this application on Feb 5, 1988. Its Orange Book therapeutic-equivalence code is AT.
Strength
20 mg/mL
Manufacturer
Saptalis Pharmaceuticals LLCNDC
71656003060
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062687FDA Approved
2/5/1988
TE Code
AT
On Market Since
8/14/2024
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 2% SOLUTION has been published 97 times since Nov 27, 2024, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3520 per ML |
|---|---|
| All-time high | $0.4321 (Apr 16, 2025) |
| All-time low | $0.3182 (Nov 27, 2024) |
| 52-week high | $0.3900 |
| 52-week low | $0.3361 |
| Median price | $0.3634 |
| Average price | $0.3709 |
| Largest weekly change | +9.1% (Dec 18, 2024) |
| Weeks tracked | 97 |
| Tracking since | Nov 27, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the erythromycin topical solution 2% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Saptalis Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
erythromycin topical solution 2% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 2% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 2% SOLUTION, manufactured by Saptalis Pharmaceuticals LLC, is $0.3520 per ML (NDC 71656003060), effective Sep 30, 2026.
How has the price of ERYTHROMYCIN 2% SOLUTION changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 2% SOLUTION has risen 10.6%. It has been tracked across 97 weekly CMS publications since Nov 27, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 2% SOLUTION?
Since Nov 27, 2024, the NADAC for ERYTHROMYCIN 2% SOLUTION has ranged from a low of $0.3182 (Nov 27, 2024) to a high of $0.4321 (Apr 16, 2025), with a median of $0.3634 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 2% SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of ERYTHROMYCIN 2% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN 2% SOLUTION?
ERYTHROMYCIN 2% SOLUTION (NDC 71656003060) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a generic product.